Distinguished Fellows

Home / Awards / Distinguished Fellows

"It is hard to overestimate the benefits I have derived from being actively engaged in CASSS for almost 3 decades. To have my professional and personal CASSS career ‘adventure’ include being selected as a Distinguished Fellow is a wonderful bonus that caps an already extraordinary set of CASSS experiences." 

–Nadine Ritter, 2022 Distinguished Fellow

"As an active participant in CASSS activities since 1996, I have had the opportunity to meet and interact with many of my peers in the biopharmaceutical industry, regulatory agencies, and academics all working toward a common goal of making better medicines to solve the world’s health problems."

–Mark Schenerman, 2022 Distinguished Fellow

Distinguished Fellows

The Board of Directors recognizes individuals noted for their outstanding contributions to CASSS, our community, and the industry overall. These individuals are honored with the title of Distinguished Fellow, bestowed on less than 1% of our members, and offered lifetime membership in CASSS.

Appointed Distinguished Fellows

Image of male with text 'CASSS Distinguished Fellow John Dougherty'

John Dougherty
EEJD Biotech Consulting LLC

Image of male with text 'CASSS Distinguished Fellow Reed Harris'

Reed Harris
Genentech, a Member of the Roche Group (retired)

The CASSS Board of Directors honored longtime volunteers John Dougherty and Reed Harris as Distinguished Fellows.

Read More 


Distinguished Fellows

  • John Dougherty – EEJD Biotech Consulting LLC, USA
  • Reed Harris – Genentech, a Member of the Roche Group (retired), USA
  • Nadine Ritter – Global Biotech Experts, LLC, USA
  • Mark Schenerman – CMC Biotech-MAS Consulting, USA
  • Frantisek Svec – Lawrence Berkeley Laboratory, USA
  • Robert Stevenson – American Laboratory/ Labcompare, USA
  • Joseph Pesek – San Jose State University, USA
  • Wassim Nashabeh – Genentech, a Member of the Roche Group, USA
  • Ron Majors – Agilent Technologies, Inc. (retired), USA
  • Michael Kunitani – Marin Analytical Consulting, USA
  • Barry Karger – The Barnett Institute, Northeastern University (retired), USA
  • John Hobbs – Beckman Coulter (retired), USA
  • Michael Henry – Queensland Health Forensic and Scientific Services Brisbane, Australia
  • William Hancock – Northeastern University, USA
  • John Frenz – Alnylam Pharmaceuticals (retired), USA
  • David Carr – Bioanalytical Technologies, USA